2017 Annual Meeting | C127 - Neuroendocrine Update: Nuts and Bolts of What You Need to Know
| 01:00 PM - 01:05 PM | Luncheon |
Introduction
Alison M. Pack, MD, FAAN |
| 01:05 PM - 01:25 PM | Speaker |
Neuroendocrine Axes: Hypothalamus, Pituitary, and Beyond
Karen K. Miller, MD |
| 01:25 PM - 01:45 PM | Speaker |
Epilepsy, Antiepileptic Drugs, and Neuroendocrine Effects
Alison M. Pack, MD, FAAN |
| 01:45 PM - 02:05 PM | Speaker |
Neuroendocrine Effects on Multiple Sclerosis
Riley Bove, MD, FAAN |
| 02:05 PM - 02:25 PM | Speaker |
Neuroendocrine Effects on Headache
Michael A. Rogawski, MD, PhD |
| 02:25 PM - 02:45 PM | Speaker |
Neuroendocrine Effects of Traumatic Brain Injury
Gary M. Abrams, MD, FAAN |
| 02:45 PM - 03:00 PM | Q&A |
Questions and Answers
|
| Gary M. Abrams, MD, FAAN | No disclosure on file |
| Michael A. Rogawski, MD, PhD | Dr. Rogawski has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Xenon Pharmaceuticals. |
| Alison M. Pack, MD, FAAN | An immediate family member of Dr. Pack has received personal compensation for serving as an employee of REGENEXBIO. The institution of Dr. Pack has received research support from National Institutes of Health. Dr. Pack has received publishing royalties from a publication relating to health care. |
| Riley Bove, MD, FAAN | Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeurologyLive. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Roche Genentech. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Eli Lilly. |
| Karen K. Miller, MD | Dr. Klahr Miller has stock in Amgen. Dr. Klahr Miller has stock in Bristol-Myers Squibb . Dr. Klahr Miller has stock in GE. Dr. Klahr Miller has stock in Boston Scientific. Dr. Klahr Miller has stock in Becton Dickinson. An immediate family member of Dr. Klahr Miller has stock in Bristol-Myers Squibb . An immediate family member of Dr. Klahr Miller has stock in GE. An immediate family member of Dr. Klahr Miller has stock in Boston Scientific. An immediate family member of Dr. Klahr Miller has stock in Bristol-Myers Squibb . The institution of Dr. Klahr Miller has received research support from Amgen. The institution of Dr. Klahr Miller has received research support from Pfizer. Dr. Klahr Miller has received publishing royalties from a publication relating to health care. |